triazinate has been researched along with Sarcoma, Epithelioid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benjamin, RS; Ho, DH; Leavens, M; Loo, TL; Lu, K; Stewart, DJ; Wang, YM; Yap, HY | 1 |
| Banner, RL; Benjamin, RS; Bodey, GP; Burgess, MA; Freireich, EJ; Gutterman, JU; Murphy, WK; Richman, SP; Rodriguez, V; Valdivieso, M | 1 |
| Benjamin, RS; Coltman, CA; O'Bryan, RM; Thigpen, JT | 1 |
3 other study(ies) available for triazinate and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Central nervous system pharmacology of Baker's antifolate (NSC139105) in man.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Glioblastoma; Humans; Lung Neoplasms; Meningeal Neoplasms; Muscles; Sarcoma; Triazines | 1984 |
Phase 2 study with Baker's Antifol in solid tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Eruptions; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Rectal Neoplasms; Remission, Spontaneous; Sarcoma; Stomatitis; Triazines | 1977 |
Phase II trial of Baker's antifol in metastatic sarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Drug Evaluation; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Triazines | 1977 |